NCT03264989 · Interventional trial
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
Overall registry status Completed
Phase 2
Conditions Sickle Cell Disease (SCD)
Delaware Valley sites
- Childrens Hospital Of Philadelphia Patient Treatment · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory